Duloxetine in the Treatment of Stress Urinary Incontinence.

• Status: Completed
• Trial end date: 2006-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to monitor the long term safety of duloxetine in the treatment of stress urinary incontinence.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company
• Collaborator: Boehringer Ingelheim
• Treatments: Duloxetine Hydrochloride

Criteria

Inclusion Criteria:

• Women with predominant stress urinary incontinence.

• 7 or more incontinence episodes per week.

Exclusion Criteria:

• Use of monoamine inhibitors.